2021
DOI: 10.1101/2021.06.25.449905
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) Up to 15 Months Post-Infection

Abstract: The recent COVID-19 pandemic is a treatment challenge in the acute infection stage but the recognition of chronic COVID-19 symptoms termed post-acute sequelae SARS-CoV-2 infection (PASC) may affect up to 30% of all infected individuals. The underlying mechanism and source of this distinct immunologic condition three months or more after initial infection remains elusive. Here, we investigated the presence of SARS-CoV-2 S1 protein in 46 individuals. We analyzed T-cell, B-cell, and monocytic subsets in both seve… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
22
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(26 citation statements)
references
References 27 publications
1
22
0
Order By: Relevance
“…More recently, elevated NC. Mono was reported to persist up to 16 months post infection among post-acute sequelae SARS-CoV-2 or long-COVID-19 patients in the presence of TNF (70,82). Indeed we observed higher levels of TNF-a that can promote the survival of NC.…”
Section: Discussionsupporting
confidence: 45%
“…More recently, elevated NC. Mono was reported to persist up to 16 months post infection among post-acute sequelae SARS-CoV-2 or long-COVID-19 patients in the presence of TNF (70,82). Indeed we observed higher levels of TNF-a that can promote the survival of NC.…”
Section: Discussionsupporting
confidence: 45%
“…These efficiently express RNAse L inhibitors and hence interfered with prompt interferon responses 37 . Linking to SARs-CoV-2, the subunit 1 (S1) persists for up to 15 months post infection and is related to post-acute inflammatory sequalae presenting with neurological complications 38 . 75% of Patients with persistent RNAemia also present long COVID 39 .…”
Section: Hypothetical Viral: Mrna Vaccine Interactionsmentioning
confidence: 99%
“…437  Another "vascular" hypothesis has focused on the possible role of non-classical monocytes rendered dysfunctional and long lived from persistent intracellular SARS CoV-2 S1 protein. 438 The high CCL5/RANTES levels secreted by these monocytes may foster endothelial dysfunction and inappropriate vasodilation. The proponents of this hypothesis claim to have successfully treated "thousands" of Long Covid patients with a therapy including an CCL5 antagonist.…”
Section: Covid-19 To the Rescuementioning
confidence: 99%